Eli Lilly (NYSE: LLY) has been one of the best-performing healthcare giants over the past decade. It now stands as the ...

Of the first six trading days in October, the Lilly Endowment has made sales on five of them. The most recent transaction ...

As researchers scramble to develop compounds that will be even safer and more effective for weight loss than currently ...

Eli Lilly's experimental weight-loss pill showed superior blood sugar control in diabetic patients across two late-stage ...

Lilly’s legal offensive against compounders of its popular weight loss drugs hits another snag in court.

Eli Lilly (NYSE: LLY) is now known for its weight loss drugs. Its stock has risen 150% since mid-2022 because of high demand ...

South Africa's Aspen Pharmacare said on Monday it had secured regulatory approval to market Eli Lilly's blockbuster diabetes ...

Lilly’s weight loss pill succeeds in late stage trial; Novo acquires a new drug; Pfizer on U.S.-China partnerships.

We recently published 10 Stocks to Watch Ahead of Q3 Earnings Season. Eli Lilly and Company (NYSE:LLY) is one of the stocks ...

Wall Street analysts can't agree on Novo Nordisk ( NVO -2.96%), with Morgan Stanley recently cutting its rating to ...

After nearly two years of sideways price action, Eli Lilly stock could soar to new highs between now and 2030.

Eli Lilly's weight-loss drug Mounjaro clocked Rs 80 crore in September sales, a 42% rise month-on-month, becoming India's ...